Published in Cancer Weekly, August 15th, 2006
CytoCore's CEO David Weissberg stated, "We have essentially completed our financial restructuring efforts and are entering into the next phase of our development activities. We have clinical trials and product manufacturing that we are about to launch. In order to maximize our success with these activities, it requires senior regulatory advice and guidance. We wanted to find a group that had successfully consulted with early-stage medical device companies. With Beaufort Advisors, we believe we have a firm that will strongly complement our existing team as we move...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.